Latest BioLife Solutions Inc. Stories
BOTHELL, Wash., April 15, 2015 /PRNewswire/ -- BioLife Solutions, Inc.
Conference Call and Webcast at 4:30pm Eastern Time BOTHELL, Wash., March 12, 2015 /PRNewswire/ -- BioLife Solutions,
BOTHELL, Wash., March 6, 2015 /PRNewswire/ -- BioLife Solutions, Inc.
No Mortality or Toxicity Noted With CryoStor Deployed as Vehicle Solution for Cells and Placebo in Direct Intramyocardial Injections BOTHELL, Wash., March 3, 2015 /PRNewswire/ --
10% Dextran 40 in 0.9% NaCl or 5% Dextrose Packaged in Bulk Bag Containers for Cell Preparation BOTHELL, Wash., Feb.
Proprietary Products Revenue Growth of 25% over 2013; HypoThermosol® and CryoStor® Now Embedded in 175 Regenerative Medicine Clinical Trials BOTHELL, Wash., Jan.
Proprietary, Clinical Grade HypoThermosol® and CryoStor® Extending Shelf Life and Improving Survival & Function of CAR-T Cells, Dendritic Cells, Etc. BOTHELL, Wash., Jan.
BOTHELL, Wash., Dec. 24, 2014 /PRNewswire/ -- BioLife Solutions, Inc.
Key Executive Will Support Adoption of biologistex(SM) Cold Chain Management Service and EVO(TM) Smart Containers for Temperature Sensitive Biologics BOTHELL, Wash., Dec.
BOTHELL, Wash., Nov. 25, 2014 /PRNewswire/ -- BioLife Solutions, Inc.
- A serpent whose bite was fabled to produce intense thirst.